Fresenius Medical Care AG & Co. (Pref) (ETR:FME) has been assigned a €94.00 ($104.44) price objective by analysts at Berenberg Bank in a note issued to investors on Wednesday. The firm currently has a a “buy” rating on the stock.

Several other equities analysts also recently commented on FME. Jefferies Group set a €82.00 ($91.11) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a report on Wednesday, August 3rd. Bankhaus Lampe set a €80.00 ($88.89) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Tuesday, August 2nd. Morgan Stanley set a €92.00 ($102.22) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Tuesday, July 26th. Deutsche Bank AG set a €82.00 ($91.11) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a report on Wednesday, August 3rd. Finally, Bank of America Corp. set a €94.00 ($104.44) price objective on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Tuesday, May 24th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the stock. Fresenius Medical Care AG & Co. (Pref) currently has a consensus rating of “Buy” and an average target price of €88.97 ($98.86).

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Shares of Fresenius Medical Care AG & Co. (ETR:FME) opened at 80.28 on Wednesday. Fresenius Medical Care AG & Co. has a 12 month low of €67.50 and a 12 month high of €85.52. The company has a market cap of €24.55 billion and a P/E ratio of 22.25. The company’s 50 day moving average is €80.72 and its 200 day moving average is €78.01.

About Fresenius Medical Care AG & Co. (Pref)

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.